Pilko G - Search Results

1

The role of neoadjuvant chemotherapy in patients with advanced (stage IIIC) epithelial ovarian cancer.

Škof E, Merlo S, Pilko G, Kobal B. Škof E, et al. Among authors: pilko g. Radiol Oncol. 2016 Jul 19;50(3):341-6. doi: 10.1515/raon-2016-0034. eCollection 2016 Sep 1. Radiol Oncol. 2016. PMID: 27679552 Free PMC article.

2

Lower tumour burden and better overall survival in melanoma patients with regional lymph node metastases and negative preoperative ultrasound.

Pilko G, Zgajnar J, Music M, Hocevar M. Pilko G, et al. Radiol Oncol. 2012 Mar;46(1):60-8. doi: 10.2478/v10019-011-0028-1. Epub 2011 Sep 22. Radiol Oncol. 2012. PMID: 22933981 Free PMC article.

3

Locoregional disease control after external beam radiotherapy in 91 patients with differentiated thyroid carcinoma and pT4 tumor stage - a single institution experience.

Besic N, Dremelj M, Pilko G. Besic N, et al. Among authors: pilko g. Radiol Oncol. 2018 Sep 22;52(4):453-460. doi: 10.2478/raon-2018-0038. Radiol Oncol. 2018. PMID: 30244234 Free PMC article. Clinical Trial.

4

Papillary thyroid microcarcinoma: prognostic factors and treatment.

Besic N, Pilko G, Petric R, Hocevar M, Zgajnar J. Besic N, et al. Among authors: pilko g. J Surg Oncol. 2008 Mar 1;97(3):221-5. doi: 10.1002/jso.20935. J Surg Oncol. 2008. PMID: 18050283

5

Prognostic heterogeneity after the excision of lymph node metastases in patients with cutaneous melanoma.

Pilko G, Besic N, Zgajnar J, Hocevar M. Pilko G, et al. Surg Oncol. 2011 Mar;20(1):26-34. doi: 10.1016/j.suronc.2009.09.004. Epub 2009 Nov 8. Surg Oncol. 2011. PMID: 19900803 Review.

6

Residual melanoma after an excisional biopsy is an independent prognostic factor for local recurrence and overall survival.

Hocevar M, Dragonja Z, Pilko G, Gazic B, Zgajnar J. Hocevar M, et al. Among authors: pilko g. Eur J Surg Oncol. 2014 Oct;40(10):1271-5. doi: 10.1016/j.ejso.2014.03.002. Epub 2014 Mar 12. Eur J Surg Oncol. 2014. PMID: 24656456

7

Surgical treatment of breast cancer in patients aged 80 years or older--how much is enough?

Besic N, Besic H, Peric B, Pilko G, Petric R, Zmuc J, Dzodic R, Perhavec A. Besic N, et al. Among authors: pilko g. BMC Cancer. 2014 Sep 23;14:700. doi: 10.1186/1471-2407-14-700. BMC Cancer. 2014. PMID: 25249067 Free PMC article.

8

Predicting nodal response to neoadjuvant treatment in breast cancer with core biopsy biomarkers of tumor microenvironment using data mining.

Pislar N, Gasljevic G, Matos E, Pilko G, Zgajnar J, Perhavec A. Pislar N, et al. Among authors: pilko g. Breast Cancer Res Treat. 2024 Nov 4. doi: 10.1007/s10549-024-07539-9. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 39496911

9

Aggressiveness of therapy and prognosis of patients with Hürthle cell papillary thyroid carcinoma.

Besic N, Hocevar M, Zgajnar J, Petric R, Pilko G. Besic N, et al. Among authors: pilko g. Thyroid. 2006 Jan;16(1):67-72. doi: 10.1089/thy.2006.16.67. Thyroid. 2006. PMID: 16487016

10

Is preoperative ultrasound of the axilla necessary in screen-detected breast cancer?

Perhavec A, Miklavčič M, Perić B, Pilko G, Žgajnar J. Perhavec A, et al. Among authors: pilko g. Eur J Surg Oncol. 2020 Jan;46(1):85-88. doi: 10.1016/j.ejso.2019.09.147. Epub 2019 Sep 19. Eur J Surg Oncol. 2020. PMID: 31582322

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters